Azellon Cell Therapeutics is focused on developing stem cell therapy for the repair of avascular meniscal tears.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: London
State: England
Zip:
Country: United Kingdom
Azellon is focused on developing stem cell therapy for the repair of avascular meniscal tears. Today orthopaedic surgeons are partially or fully removing the meniscus which over 4-6 years will lead to osteoarthritic changes in the knee joint. The technology behind Azellon was developed by Professor Anthony Hollander over the last 5 years and has already been proven highly successful in an in-vitro model.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2015 | Venture Round | 3 | $814.3k |
IP Group Longwall Venture Partners Oxford Technology Management IP Group Longwall Venture Partners Oxford Technology Management |
11/2011 | Venture Round | 2 | $1M |
IP Group Oxford Technology Management IP Group Oxford Technology Management |
4/2009 | Seed Round | $0 |
Innovate UK IP Group Oxford Technology Management University of Bristol Wellcome Trust Wyvern Seed Fund Innovate UK IP Group Oxford Technology Management University of Bristol Wellcome Trust Wyvern Seed Fund |
4/2009 | Seed Round | 6 | $2.3M |
Innovate UK IP Group Oxford Technology Management University of Bristol Wellcome Trust Wyvern Seed Fund Innovate UK IP Group Oxford Technology Management University of Bristol Wellcome Trust Wyvern Seed Fund |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|